Cantor analyst Sung Ji Nam has high hopes for Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG), upgrading shares to Buy and raising the price target to …
In a research report issued today, Cantor analyst Sung Ji Nam reiterated a Buy rating on TrovaGene Inc (NASDAQ:TROV) with an $8 price target, after several …
